Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00642681 · ClinicalTrials.gov registry record
Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge
A clinical trial of Diabetes Mellitus and Upper Respiratory Infection, sponsored by Mannkind Corporation.
- Completed
- Registry status
- 20
- Enrollment target
- 20
- Study locations
NCT00642681: Completed study of Diabetes Mellitus and Upper Respiratory Infection, sponsored by Mannkind Corporation.
NCT00642681 is a study of Diabetes Mellitus and Upper Respiratory Infection that has completed, run by Mannkind Corporation. The registered enrollment target is 20 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00642681, a study of Diabetes Mellitus and Upper Respiratory Infection, has completed, sponsored by Mannkind Corporation.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 20
- Study locations
Study Summary
Effect of upper respiratory infection (URI) on diabetic subjects with a meal challenge
Conditions Studied
Interventions
- DRUG Technosphere Insulin
Study Locations (20)
RUS
- Kemerovo State Medical Academy of Ministry of Health - Kemerovo
- NHI Kemerovo Regional Clinical Hospital - Kemerovo
- Russian State Medical University City Hospital # 4 - Moscow
- RAAMS Endocrinology and Diabetology Department - Moscow
California
- Valley Research (Norwood) - Fresno
- Diabetes/Lipid Management and Research Center - Huntington Beach
Georgia
- Private Practice - Decatur
- Endocrine Research Solutions, Inc. - Roswell
Ohio
- Rapid Medical Research Inc - Cleveland
- Your Diabetes Endocrine Nutrition Group - Mentor
Arizona
- Arizona Research Associates - Tuscon
Illinois
- Cedar-Crosse Research Center - Chicago
Maryland
- MODEL Clinical Research - Baltimore
Missouri
- Healthcare Research - Florissant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-08 |
What the finished NCT00642681 record still lists
NCT00642681 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Technosphere Insulin is the first listed.
NCT00642681 names 20 study sites across 14 states, led by RUS, California, Georgia.
Frequently Asked Questions
What is clinical trial NCT00642681 about?
NCT00642681 is a clinical study titled "Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge". Effect of upper respiratory infection (URI) on diabetic subjects with a meal challenge
What is the current status of trial NCT00642681?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2007-12. Estimated completion is 2008-08.
What conditions does trial NCT00642681 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Upper Respiratory Infection.
What interventions are being tested in trial NCT00642681?
The interventions under investigation include: Technosphere Insulin (DRUG).
Who is sponsoring clinical trial NCT00642681?
This trial is sponsored by Mannkind Corporation, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00642681 being conducted?
This trial has 20 study locations across Arizona, California, Georgia, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00642681's enrollment target sits among peer trials
20 195th of 208 higher than 11 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genetic Studies of Insulin and Diabetes
RECRUITING
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
RECRUITING
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia